The Sydney Melanoma Unit was a department of restricted status within the Faculty of Medicine at The University of Sydney. With the evolution of the Melanoma Institute Australia this relationship continues through an affiliation agreement. Both organisations are working together to find better treatments for melanoma skin cancer.
St Vincents and Mater Health Sydney is the NSW-based arm of St Vincent's Health Australia which, together with its partners, is one of Australia's leading Catholic not-for-profit diversified healthcare providers.
The $40 million donation from Mr Greg Poche to construct the Poche Centre was given to the Mater Hospital, a facility of St Vincents & Mater Health Sydney, on the condition that a building was constructed for melanoma research, treatment and education. This led to the development of a partnership between St Vincents and Mater Health Sydney and Melanoma Institute Australia.
The Royal Prince Alfred Hospital is the principal teaching hospital of The University of Sydney. Melanoma Institute Australia surgeons have benefited enormously from the extensive range of diagnostic and treatment services provided by one of Australia’s leading hospitals.
ANZMTG aims to bring together researchers, clinicians, health care professionals and consumers with an interest in melanoma clinical trials to foster collaboration and the exchange of ideas.